News Search Results
Jun 15, 2026, 16:00 ET High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM
products.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company, with a 14% share of the German medical cannabis market, built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers,
More news about: High Tide Inc.
Jun 15, 2026, 06:15 ET High Tide Secures Credit Approval for C$40MM of Senior Secured Credit Facilities
Germany.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company, with a 14% share of the German medical cannabis market, built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers,
More news about: High Tide Inc.
Jun 15, 2026, 06:00 ET High Tide to Acquire Northern Helm, Adding Four Established Retail Cannabis Stores in Ontario
Germany.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company, with a 14% share of the German medical cannabis market, built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers,
More news about: High Tide Inc.
Jun 11, 2026, 07:05 ET Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results with Record Annual Revenue and Adjusted EBITDA¹
exceeded our projection for global medical cannabis net revenue1 led by double-digit growth in Europe and delivered on our expectation for Adjusted EBITDA1 with both at record outcomes. Our performance validates Aurora's global medical cannabis strategy which has positioned us as
More news about: Aurora Cannabis Inc.
Jun 10, 2026, 11:00 ET High Tide to Open Two New Canna Cabana Locations in Welland and Calgary
Germany.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company, with a 14% share of the German medical cannabis market, built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers,
More news about: High Tide Inc.
Jun 10, 2026, 08:00 ET From Appalachia to Greenland: The New American Rare Earth Map
actual results to differ include, but are not limited to, changing governmental laws and policies concerning, among other things, recreational and medical cannabis sales, success of the company's proprietary technology, the size and growth of the market for the company's products and services, the company's
More news about: OilPrice.com
Jun 09, 2026, 17:24 ET IM Cannabis Announces Form F-3 Resale Registration Statement Filing
Israel, June 9, 2026 /CNW/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that, further to its press releases dated May 7, 2026 and June 3, 2026, it has filed
More news about: IM Cannabis Corp.
Jun 09, 2026, 17:24 ET IM Cannabis Announces Form F-3 Resale Registration Statement Filing
June 9, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that, further to its press releases dated May 7, 2026 and June 3, 2026, it has filed
More news about: IM Cannabis Corp.
Jun 09, 2026, 08:00 ET Trulieve Announces Share Repurchase Program
TCNNF) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that its Board of Directors authorized a share repurchase program pursuant to which the Company may repurchase
More news about: Trulieve Cannabis Corp.
Jun 09, 2026, 01:00 ET Seed Junky Genetics Expands into Europe Through Strategic Partnership with Green Success Group
Kingdom medical cannabis marketsLOS ANGELES, June 9, 2026 /PRNewswire/ -- Seed Junky Genetics, a globally recognized cannabis genetics and intellectual property company, is expanding into the European medical cannabis market
More news about: Seed Junky Genetics
Jun 05, 2026, 07:00 ET Trulieve Announces Uplist to NYSE
TCNNF) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that its subordinate voting shares (the "Subordinate Voting Shares") have been approved for listing on the
More news about: Trulieve Cannabis Corp.
Jun 04, 2026, 13:00 ET Western Rare Earth Supply Chains Are Finally Taking Shape
actual results to differ include, but are not limited to, changing governmental laws and policies concerning, among other things, recreational and medical cannabis sales, success of the company's proprietary technology, the size and growth of the market for the company's products and services, the company's
More news about: OilPrice.com
Jun 04, 2026, 06:00 ET NATIONAL COMPASSIONATE CARE COUNCIL ANNOUNCES MEDICAL ADVISORY BOARD TO GUIDE REFORM AGENDA
Medical Advisor. "This advisory board represents an important step toward ensuring that real-world evidence and clinical expertise remain central to medical cannabis reform. The caliber of physicians involved reflects the growing urgency within the medical community to bridge the gap between clinical reality
More news about: National Compassionate Care Council
Jun 03, 2026, 16:01 ET IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
Israel, June 3, 2026 /CNW/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$225,000 convertible note financing in a private placement with
More news about: IM Cannabis Corp.
Jun 03, 2026, 16:01 ET IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
June 3, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$225,000 convertible note financing in a private placement with
More news about: IM Cannabis Corp.
Jun 03, 2026, 06:00 ET High Tide to Announce Second Fiscal Quarter 2026 Financial Results
Germany.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company, with a 14% share of the German medical cannabis market, built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers,
More news about: High Tide Inc.
Jun 02, 2026, 07:07 ET Aurora Deepens its Impact for Veterans Across Canada
June 2, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, shares recent contributions through its Strains for Heroes program, expanding support for Veteran communities across Canada. Aurora's
More news about: Aurora Cannabis Inc.
Jun 01, 2026, 08:49 ET Patient First Coalition Supports DEA's Medical Cannabis Review Process Providing Experts Advocating for Schedule III Transition Moritorium - Supporting Medical
regulators as they evaluate the future framework of medical cannabis in America."The transition of medical cannabis represents one of the most significant healthcare policy shifts of our generation," said Kari Boiter, Patient First Coalition Medical Cannabis Committee member and Legislative Sub-Committee
More news about: Patient First Coalition
May 28, 2026, 11:18 ET Illinois Action Center: Major Cannabis Reform Could Move Forward in Illinois Under HB 5784
would allow any adult-use dispensary to apply for a medical cannabis dispensing license at no cost. The bill would also remove the designated-dispensary requirement, helping medical patients access cannabis at more locations and receive medical cannabis tax rates where approved.Authorizing Drive-Through
More news about: Illinois Action Center
May 28, 2026, 11:07 ET Speakeasy Dispensary Brings Medical Cannabis Access to Bowling Green
/PRNewswire/ -- Speakeasy Dispensary will officially open its newest Kentucky medical cannabis location in Bowling Green on Friday, June 5, increasing access for patients throughout South Central Kentucky as the state's medical cannabis program continues to expand.
More news about: Speakeasy Dispensary
May 28, 2026, 09:45 ET The Rare Earth Race Has a New Front-Runner
actual results to differ include, but are not limited to, changing governmental laws and policies concerning, among other things, recreational and medical cannabis sales, success of the company's proprietary technology, the size and growth of the market for the company's products and services, the company's
More news about: OilPrice.com
May 28, 2026, 08:00 ET Greenway Reports Expanded International Cannabis Sales
Since commencing international shipments in late 2024, Greenway has continued to methodically increase its exposure to the worldwide medical cannabis markets through established strategic partnerships and disciplined commercial execution.The Company's global growth strategy has focused
More news about: Greenway Greenhouse Cannabis Corporation
May 28, 2026, 07:05 ET Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2026 Investor Conference Call and File Related Year End Information
May 28, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and fiscal year 2026 on Thursday,
More news about: Aurora Cannabis Inc.
May 26, 2026, 08:45 ET New GCNC and Whitney Economics Report Examines Europe's Expanding Role in Global Cannabis Markets
Whitney Economics, examines how medical cannabis expansion, international trade, pharmaceutical manufacturing standards, and evolving regulatory frameworks are transforming the EU and UK into
More news about: GCNC
May 26, 2026, 08:45 ET New GCNC and Whitney Economics Report Examines Europe's Expanding Role in Global Cannabis Markets
Whitney Economics, examines how medical cannabis expansion, international trade, pharmaceutical manufacturing standards, and evolving regulatory frameworks are transforming the EU and UK into
More news about: GCNC